(Ron Adar/SOPA Images/Reuters Connect)
Family names have long given candidates a boost. In the era of No Kings, they can also make for an easy attack.
By Teo Armus
(The Washington Post illustration; iStock)
Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer prevention and treatment.
By Ariana Eunjung Cha and Christopher Rowland
Have a moral dilemma or a personal problem you can't seem to solve? Don't miss Post columnist Carolyn Hax's latest column every day.